SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-044508
Filing Date
2024-04-15
Accepted
2024-04-15 17:21:50
Documents
97
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K alrn-20231231.htm   iXBRL 10-K 3002301
2 EX-3.3 alrn-ex3_3.htm EX-3.3 13120
3 EX-4.2 alrn-ex4_2.htm EX-4.2 28748
4 EX-10.11 alrn-ex10_11.htm EX-10.11 121421
5 EX-10.42 alrn-ex10_42.htm EX-10.42 182193
6 EX-21.1 alrn-ex21_1.htm EX-21.1 13440
7 EX-23.1 alrn-ex23_1.htm EX-23.1 2687
8 EX-23.2 alrn-ex23_2.htm EX-23.2 6306
9 EX-31.1 alrn-ex31_1.htm EX-31.1 11323
10 EX-31.2 alrn-ex31_2.htm EX-31.2 13698
11 EX-32.1 alrn-ex32_1.htm EX-32.1 7093
12 EX-32.2 alrn-ex32_2.htm EX-32.2 7817
13 EX-97.1 alrn-ex97_1.htm EX-97.1 24133
  Complete submission text file 0000950170-24-044508.txt   11351414

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alrn-20231231.xsd EX-101.SCH 1679848
101 EXTRACTED XBRL INSTANCE DOCUMENT alrn-20231231_htm.xml XML 1505076
Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Aileron Therapeutics, Inc. (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 134196017 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38130 | Film No.: 24845506
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)